GenMont Biotech Incorporation (TPE:3164)

TPE:3164 Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	368.41	385.37	318.02	368.55	427.93	325.19
Revenue Growth (YoY)	3.83%	21.18%	-13.71%	-13.88%	31.59%	-6.08%
Cost of Revenue	146.86	147.19	106.82	111.83	128.6	109.8
Gross Profit	221.55	238.18	211.19	256.72	299.33	215.39
Selling, General & Admin	153.33	152.79	156.6	137.12	145.47	118.73
Research & Development	46.27	45.27	46.86	59.41	25.52	26.3
Operating Expenses	201.42	197.55	204.2	194.75	174.29	144.42
Operating Income	20.13	40.63	6.99	61.97	125.04	70.97
Interest Expense	-4.12	-3.72	-0.97	-0.76	-0.77	-0.81
Interest & Investment Income	11.24	11.6	9.46	4.8	2.35	2.89
Earnings From Equity Investments	-	-	-	-	-	-0.1
Currency Exchange Gain (Loss)	14.74	17.05	-6.98	10.45	-1.35	-1.34
Other Non Operating Income (Expenses)	0.62	0.4	0.34	-1.98	1.06	0.82
EBT Excluding Unusual Items	42.62	65.97	8.83	74.48	126.34	72.44
Gain (Loss) on Sale of Investments	-0.96	-1.23	19.05	-8.16	9.35	-3.32
Gain (Loss) on Sale of Assets	-0.02	-0.02	0.28	-0.06	3.74	0.24
Other Unusual Items	-	-	-	-	-	7.49
Pretax Income	41.64	64.72	28.16	66.26	139.42	76.85
Income Tax Expense	12.16	16.97	5.73	18.8	29.82	16.63
Earnings From Continuing Operations	29.48	47.75	22.43	47.46	109.6	60.22
Net Income to Company	29.48	47.75	22.43	47.46	109.6	60.22
Minority Interest in Earnings	9.49	9.5	10.56	9.52	3.53	0.67
Net Income	38.96	57.25	32.99	56.98	113.13	60.88
Net Income to Common	38.96	57.25	32.99	56.98	113.13	60.88
Net Income Growth	-34.52%	73.53%	-42.10%	-49.64%	85.82%	5.98%
Shares Outstanding (Basic)	87	87	86	86	86	88
Shares Outstanding (Diluted)	87	87	87	87	87	88
Shares Change (YoY)	0.16%	0.18%	-0.10%	-0.09%	-1.50%	-1.34%
EPS (Basic)	0.45	0.66	0.38	0.66	1.31	0.69
EPS (Diluted)	0.45	0.66	0.38	0.66	1.30	0.69
EPS Growth	-33.83%	73.68%	-42.40%	-49.25%	88.41%	7.81%
Free Cash Flow	97.2	79.89	1.29	65.79	-5.28	-20.5
Free Cash Flow Per Share	1.12	0.92	0.01	0.76	-0.06	-0.23
Dividend Per Share	0.800	0.800	0.500	0.700	1.100	0.700
Dividend Growth	60.00%	60.00%	-28.57%	-36.36%	57.14%	-12.50%
Gross Margin	60.14%	61.80%	66.41%	69.66%	69.95%	66.23%
Operating Margin	5.46%	10.54%	2.20%	16.81%	29.22%	21.82%
Profit Margin	10.58%	14.86%	10.37%	15.46%	26.44%	18.72%
Free Cash Flow Margin	26.38%	20.73%	0.41%	17.85%	-1.23%	-6.30%
EBITDA	87.24	108.18	68.77	109.92	143.05	88.77
EBITDA Margin	23.68%	28.07%	21.63%	29.82%	33.43%	27.30%
D&A For EBITDA	67.11	67.55	61.79	47.95	18.02	17.8
EBIT	20.13	40.63	6.99	61.97	125.04	70.97
EBIT Margin	5.46%	10.54%	2.20%	16.81%	29.22%	21.82%
Effective Tax Rate	29.21%	26.22%	20.35%	28.37%	21.39%	21.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.